Nestle SA logo

NESN - Nestle SA News Story

CHF117.8 -0.4  -0.3%

Last Trade - 02/12/21

Consumer Defensives
Large Cap
Market Cap £265.43bn
Enterprise Value £297.48bn
Revenue £69.38bn
Position in Universe 1st / 1049

Nestle Holdings Inc Nestle Fin Intl Ltd Nestle SA - Publication of Suppl.Prospcts

Thu 4th March, 2021 2:45pm
RNS Number : 2330R
Nestle Holdings Inc
04 March 2021

Nestlé Holdings, Inc.

Nestlé Finance International Ltd.


4 March 2021


Publication of Prospectus Supplement

Nestlé Holdings, Inc. and Nestlé Finance International Ltd. (the "Issuers") have published a Prospectus Supplement dated 4 March 2021 (the "Prospectus Supplement") in respect of their Debt Issuance Programme and the publication on 18 February 2021 of the audited annual consolidated financial statements for the financial year ended 31 December 2020 of Nestlé S.A. (the "Financial Information").

The Prospectus Supplement should be read and construed in conjunction with the Base Prospectus dated 29 May 2020, as supplemented by the first Prospectus Supplement dated 28 August 2020 (as so supplemented, the "Base Prospectus").

To view the Prospectus Supplement, please paste the following URL into the address bar of your browser.

To view the Financial Information, please paste the following URL into the address bar of your browser.

Copies of the Prospectus Supplement and the Financial Information will be submitted to the National Storage Mechanism and will be available shortly at: This website is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

For further information, please contact:

Nestlé S.A.

Avenue Nestlé 55

1800 Vevey
Canton of Vaud



Please note that the information contained in the Prospectus Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Prospectus Supplement, you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained in the Prospectus Supplement.

The Prospectus Supplement does not contain or constitute an offer of, or the solicitation of an offer to buy, securities to any person in the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to in the Base Prospectus may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended (the "Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The offer and sale of the securities referred to in the Base Prospectus has not been and will not be registered under the Securities Act. There will be no public offer of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.